Vortex Surgical Recalls Backflush Devices Due to Potential Sterile Barrier Breach
Areazine synthesizes this FDA recall directly from FDA's official public data feed. See our methodology for full source attribution and refresh cadence.
Vortex Surgical Inc. has recalled over 14,000 backflush surgical devices due to packaging seal voids that could lead to contamination and patient infection.
What this FDA recall tells you, and what most readers miss
This notice was issued by FDA on April 6, 2026 and geographically references United States. Its severity classification of "medium" signals how the issuing agency weighs the risk of harm if no action is taken - "critical" and "high" tier alerts typically carry direct consumer actions, while "medium" and "low" tend toward informational guidance or monitoring advisories. The category it belongs to - FDA Recalls - determines the consumer-protection framework behind it, which shapes what remedies (refunds, replacements, repairs, or the recall itself) are available to affected consumers and which agency holds statutory responsibility for enforcement.
Most readers skim a notice like this, check whether they are personally affected, and move on. The more useful lens is to verify its scope, source, and timestamp, then compare related notices without assuming that one record proves a broader trend.
Areazine pairs this record with the original agency URL so you can check the primary source before acting. Its related labels are recall, product-safety, fda, MedicalDevices.
What Happened
Vortex Surgical Inc. has initiated a voluntary recall of specific lots of its backflush surgical devices. The recall was triggered by the discovery of voids located in the seals of the Tyvek pouches used to package the instruments. A compromised sterile barrier presents a risk of bioburden contamination, which could lead to serious infections in patients during surgical procedures.
Which Products Are Affected
The recall affects a total of 14,789 units (8,651 in the United States and 6,138 internationally). The following products and lots are included:
- Vortex Surgical 25GA Backflush (Model VS0270.25)
- Lot Number: 2411017
- Pouch UDI: 810123480470
- Box UDI: 810123480753
- Vortex Surgical 25GA Backflush Retractable (Model VS0275.27)
- Lot Number: 2411016
- Pouch UDI: 810123480517
- Box UDI: 810123480791
Distribution in the United States included the following states: AL, AR, AZ, CA, CT, FL, HI, IA, IL, IN, KY, MA, MI, MN, MS, NC, NE, NJ, NM, NY, OH, OR, PA, RI, SC, SD, TN, TX, WA, WI, and VA. International distribution included Australia, Chile, China, France, Germany, India, Ireland, Italy, Japan, Korea, Mexico, Netherlands, Philippines, Poland, Puerto Rico, Spain, Switzerland, Taiwan, United Kingdom, and Vietnam.
What You Should Do
Vortex Surgical Inc. notified affected customers via a formal letter initiated on December 16, 2025. Healthcare facilities and distributors should immediately check their inventory for the affected lot numbers (2411017 and 2411016). Any affected products should be quarantined and handled according to the instructions provided in the firm's notification letter. For further information regarding returns or replacements, contact Vortex Surgical Inc. at their Saint Charles, MO headquarters.
Why This Matters
The integrity of a sterile barrier is critical for surgical instruments; any breach in the packaging seal can introduce bacteria or other contaminants, posing a significant health risk to patients undergoing invasive procedures.
Source
This information is based on an official recall notice from the FDA. Recall Number: Z-1255-2026.
Original source: FDA Official Notice ↗
Related FDA Recalls
All FDA Recalls →Frequently Asked Questions
Common questions about this FDA recall.